Organon & Co.

OGNNYSE United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$3.571 B

$13.60 +0.37%

Close of 7 Aug 2026

Revenue

$6.22B

#579 by revenue

Earnings

$187.0M

#1038 by earnings

Shares outstanding

262,609,433

Latest filing cover page

P/E ratio

19.1

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#73Arcus BiosciencesRCUS$3.64B
#74IDEAYA BiosciencesIDYA$3.57B
#75Organon & Co.OGN$3.57B
#76AlumisALMS$3.52B
#77NewAmsterdam PharmaNAMS$3.34B

Where these numbers come from

Share counts and financials for Organon & Co. are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.